Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals

NEW YORK, NY / ACCESSWIRE / March 8, 2022 / Evonik Industries AG, a leading global supplier of specialty chemicals, announced Monday their venture capital company's strategic investment with Laxxon Medical

Related Keywords

China ,Germany ,United States ,Switzerland ,German ,Swiss ,Achim Schneeberger ,Frances Hoggard ,Thomas Riermeier ,Helmut Kerschbaumer ,Lutz Stoeber ,Klaus Kuehne ,Healthcare Solutions ,Evonik Industries ,Laxxon Medical Corporation ,Technology Screen Printing Innovational Drug ,Nasdaq ,Laxxon Medical ,Evonik Venture Capital North ,Heath Care Business Line ,Chief Executive Officer ,Evonik Venture Capital ,Specialty Additives ,Smart Materials ,Screen Printing Innovational Drug Technology ,Public Relations Manager ,Evonik ,Industries ,Raxxon ,Medical ,Future ,Screen ,Rinted ,Pharmaceuticals ,